文献速递细菌感染、耐药与抗菌药物医院感染防控

碳青霉烯酶肠杆菌目细菌筛查:考量分子结果的实际意义、培养的价值及耐药判定标准

Screening for carbapenemase-producing Enterobacterales (CPE)-considering the practical implications of molecular results, the value of culture and deciding criteria for resistance.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

该研究回顾性分析2022年8月1日至2024年5月31日共61268份基于危险因素的碳青霉烯酶肠杆菌目细菌(CPE)筛查拭子,采用PCR后对阳性标本行培养的两步法。292份PCR阳性(0.5%),鉴定298个基因,其中81.5%经培养确认。ROC分析显示AUC为0.82,约登指数得出最佳Ct截断值为33.7。作者认为分子平台无法检测菌种或抗菌药物耐药性,分子后接培养的算法可减少培养工作量并提供全面数据。

要点

  • 61268份CPE筛查中292份PCR阳性(0.5%),鉴定298个基因,81.5%培养确认。
  • ROC分析AUC为0.82,约登指数得出最佳Ct截断值为33.7。
  • 33例新发PCR阳性培养阴性住院患者获得重复CPE筛查,17例(11%)无法进一步调查。

核心结论

  • 分子平台单独无法检测菌种或抗菌药物耐药性。
  • 分子后接培养的算法可减少培养相关工作负荷,产生包括抗菌药物敏感性结果在内的全面数据,以支持知情的临床、政策和流行病学决策。

研究设计与样本

  • 对2022年8月1日至2024年5月31日期间所有PCR阳性标本进行数据提取。
  • 基于危险因素的CPE筛查拭子采用两步算法检测:先PCR,后对PCR阳性标本进行培养。
  • 使用受试者工作特征(ROC)曲线估算OR以比较Ct值与培养,并计算约登指数确定最佳Ct截断值。
  • 评估新发现CPE PCR阳性患者对CPE筛查路径的依从性。

主要发现

  • 61268份CPE筛查中292份PCR阳性(0.5%),鉴定298个基因。
  • 292份PCR阳性标本中81.5%经培养确认。
  • ROC分析显示AUC为0.82,约登指数得出Ct截断值为33.7。
  • 33例新发PCR阳性、培养阴性的住院患者获得重复CPE筛查。
  • 17例(11%)新发PCR阳性、培养阴性患者无法进一步调查。

关键数值与推荐

  • 61268份CPE筛查中292份PCR阳性,阳性率0.5%。
  • 292份PCR阳性标本中81.5%经培养确认。
  • ROC分析AUC为0.82,约登指数得出最佳Ct截断值为33.7。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carbapenemase-producing Enterobacterales (CPE) are of international concern. Screening for CPE can encompass single- or two-step approaches, using culture, PCR or a combination. Each approach has benefits, but none are without disadvantage. OBJECTIVES: To reflect on the challenges and implications of PCR-positive/culture-negative CPE screening results and assess if PCR cycle threshold (Ct) value can be helpful in predicting positive culture results. PATIENTS AND METHODS: Risk factor-based CPE screening swabs were tested using a two-step algorithm: PCR followed by culture of PCR-positive specimens. Data on all PCR-positive specimens between 1 August 2022 and 31 May 2024 were extracted. ORs were estimated using receiver operating characteristic (ROC) curves to compare Ct values and culture. Youden's index was calculated to establish the optimal Ct cut-off value. Compliance with the CPE screening pathway for newly identified CPE PCR-positive patients was assessed. RESULTS: Of 61 268 CPE screens, 292 were PCR positive (0.5%), with 298 genes identified. Of these, 81.5% were culture confirmed. ROC analysis showed an AUC of 0.82 and Youden's index yielding a Ct cut-off value of 33.7. Repeat CPE screens were obtained from 33 new PCR-positive, culture-negative inpatients. Further investigation was not possible for 17 new PCR-positive, culture-negative patients (11%). CONCLUSIONS: Molecular platforms alone cannot detect species or antimicrobial resistance. A molecular-followed-by-culture algorithm can reduce workloads associated with culture, resulting in comprehensive data, including antimicrobial susceptibility results, to support informed clinical, policy and epidemiological decision-making.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Skally M, Cafferkey J, Russell M, et al. Screening for carbapenemase-producing Enterobacterales (CPE)-considering the practical implications of molecular results, the value of culture and deciding criteria for resistance. J Antimicrob Chemother. 2025. PMID: 40105887. doi:10.1093/jac/dkaf088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。